Nanobiotix S.A.
NBTX
$3.39
$0.24117.66%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 3.04% | -394.54% | |||
| Total Other Revenue | -3.04% | -57.75% | |||
| Total Revenue | 3.04% | -281.20% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 3.04% | -281.20% | |||
| SG&A Expenses | -3.04% | -8.60% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.04% | -12.09% | |||
| Operating Income | 3.04% | -94.15% | |||
| Income Before Tax | 3.04% | -117.66% | |||
| Income Tax Expenses | 2.97% | -130.45% | |||
| Earnings from Continuing Operations | 3.04% | -116.03% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.04% | -116.03% | |||
| EBIT | 3.04% | -94.15% | |||
| EBITDA | 3.04% | -95.20% | |||
| EPS Basic | 3.04% | -114.73% | |||
| Normalized Basic EPS | 3.03% | -130.87% | |||
| EPS Diluted | 3.03% | -115.29% | |||
| Normalized Diluted EPS | 3.03% | -130.87% | |||
| Average Basic Shares Outstanding | 0.00% | 0.60% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||